Green Thumb Industries (GTBIF) Long-Term Investments (2018 - 2026)
Green Thumb Industries' (GTBIF) quarterly Long-Term Investments came in at $32.7 million in Q1 2026, down 24.84% YoY from $43.5 million in Q1 2025, and little changed on a QoQ basis from $32.7 million in Q4 2025.
Green Thumb Industries (GTBIF) Long-Term Investments (2018 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 9 years of Long-Term Investments data on file, last reported at $32.7 million in Q1 2026.
- Quarterly Long-Term Investments fell 24.84% year-over-year to $32.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.7 million (down 24.84% YoY) and the FY2025 annual result came in at $32.7 million, down 24.92% from the prior year.
- Long-Term Investments held at $32.7 million in Q1 2026, from $32.7 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $90.7 million in Q1 2022 to a low of $32.7 million in Q1 2026.
- A 5-year average of $61.3 million and a median of $61.4 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments surged 212.16% — and 2024, when it plunged 32.29%.
- Tracing GTBIF's Long-Term Investments over 5 years: stood at $74.2 million in 2022, then declined by 13.22% to $64.4 million in 2023, then sank by 32.29% to $43.6 million in 2024, then decreased by 24.92% to $32.7 million in 2025, then fell by 0.17% to $32.7 million in 2026.
- The last three Long-Term Investments figures came in at $32.7 million (Q1 2026), $32.7 million (Q4 2025), and $43.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 60.00 Mn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 30.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.35 Mn |
| Mar 31, 2026 | 32.66 Mn |
| Dec 31, 2025 | 32.72 Mn |
| Sep 30, 2025 | 43.74 Mn |
| Jun 30, 2025 | 43.84 Mn |
| Mar 31, 2025 | 43.46 Mn |
| Dec 31, 2024 | 43.58 Mn |
| Sep 30, 2024 | 61.42 Mn |
| Jun 30, 2024 | 61.41 Mn |
| Mar 31, 2024 | 60.85 Mn |
| Dec 31, 2023 | 64.36 Mn |
| Sep 30, 2023 | 77.34 Mn |
| Jun 30, 2023 | 75.06 Mn |
| Mar 31, 2023 | 75.67 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 79.98 Mn |
| Jun 30, 2022 | 81.78 Mn |
| Mar 31, 2022 | 90.73 Mn |
| Dec 31, 2021 | 94.90 Mn |
| Sep 30, 2021 | 50.63 Mn |